MagicMed Industries Inc.
MagicMed Industries is a biotechnology company that is focused on creating a library of psychedelic derivatives and partnering with pharmaceutical and other companies to develop psychedelic-derived pharmaceuticals.
MagicMed’s molecular derivatives library, the Psybrary™ is intended to be an essential building block from which industry can develop new patented products.
The initial focus of the Psybrary™ is on psilocybin and is expected to be opportunistically expanded to other psychedelics like MDMA, LSD, ketamine, and ibogaine.
